Search Results - "Reife, R A"

Refine Results
  1. 1

    Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages by Faught, E, Wilder, B J, Ramsay, R E, Reife, R A, Kramer, L D, Pledger, G W, Karim, R M

    Published in Neurology (01-06-1996)
    “…We conducted a randomized double-blind comparison of three doses of the novel antiepileptic drug (AED) topiramate (200, 400, and 600 mg/day) and placebo as…”
    Get full text
    Journal Article
  2. 2

    Local Chemokine Paralysis, a Novel Pathogenic Mechanism for Porphyromonas gingivalis by DARVEAU, R. P, BELTON, C. M, REIFE, R. A, LAMONT, R. J

    Published in Infection and Immunity (01-04-1998)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    Topiramate Monotherapy for Partial Onset Seizures by Sachdeo, Rajesh C., Reife, Ross A., Lim, Pilar, Pledger, Gordon

    Published in Epilepsia (Copenhagen) (01-03-1997)
    “…Purpose: Evaluation of topiramate (TPM) as monotherapy in patients with uncontrolled partial onset seizures. Methods: A total of 48 patients were evaluated in…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Topiramate as Adjunctive Therapy in Refractory Partial Epilepsy: Pooled Analysis of Data from Five Double‐Blind, Placebo‐Controlled Trials by Reife, R. A., Pledger, G. W.

    Published in Epilepsia (Copenhagen) (01-01-1997)
    “…A pooled analysis of data from five similarly designed double‐blind, placebo‐controlled trials of topiramate (TPM) as add‐on therapy in patients with partial…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Induction of arthritis with monoclonal antibodies to collagen by Terato, K, Hasty, KA, Reife, RA, Cremer, MA, Kang, AH, Stuart, JM

    Published in The Journal of immunology (1950) (01-04-1992)
    “…mAb were developed from DBA/1 mice immunized with chick type II collagen. A total of 69 IgG antibodies was isolated and characterized. The majority (36%)…”
    Get full text
    Journal Article
  6. 6

    Porphyromonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation by REIFE, R. A, SHAPIRO, R. A, BAMBER, B. A, BERRY, K. K, MICK, G. E, DARVEAU, R. P

    Published in Infection and Immunity (01-12-1995)
    “…Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  7. 7

    A study of topiramate pharmacokinetics and tolerability in children with epilepsy by Rosenfeld, William E, Doose, Dennis R, Walker, Sally A, Baldassarre, James S, Reife, Ross A

    Published in Pediatric neurology (01-05-1999)
    “…The pharmacokinetic and safety profile of topiramate as adjunctive therapy was assessed in pediatric patients with epilepsy in an open-label, 4-week,…”
    Get full text
    Journal Article
  8. 8

    Porphyromonas gingivalis Lipopolysaccharide Antagonizes Escherichia coli Lipopolysaccharide at Toll-Like Receptor 4 in Human Endothelial Cells by COATS, Stephen R, REIFE, Robert A, BAINBRIDGE, Brian W, PHAM, Thu-Thao T, DARVEAU, Richard P

    Published in Infection and Immunity (01-12-2003)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis by Hirose, T, Reife, R A, Smith, Jr, G N, Stevens, R M, Mainardi, C L, Hasty, K A

    Published in Journal of rheumatology (01-04-1992)
    “…Gelatin degrading matrix metalloproteinases in synovial fluid from 21 patients with inflammatory arthritis were shown to consist of two distinct gene products,…”
    Get more information
    Journal Article
  10. 10

    Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non‐cartilaginous tissues during early mouse development by Sandell, Linda J., Nalin, Andrew M., Reife, Robert A.

    Published in Developmental dynamics (01-02-1994)
    “…Type II collagen, generally considered to be characteristic of cartilage, has been localized in specific non‐cartilaginous structures during embryogenesis and…”
    Get full text
    Journal Article
  11. 11

    Gene expression of collagen types IIA and IX correlates with ultrastructural events in early osteoarthrosis: new applications of the rabbit meniscectomy model by Lefkoe, T P, Nalin, A M, Clark, J M, Reife, R A, Sugai, J, Sandell, L J

    Published in Journal of rheumatology (01-06-1997)
    “…To examine the phenotypic expression and geographic distribution of collagens in early stages of osteoarthrosis and their relationship to ultrastructural…”
    Get more information
    Journal Article
  12. 12

    The role of C5 and T-cell receptor Vb genes in susceptibility to collagen-induced arthritis by SPINELLA, D. G, JEFFERS, J. R, REIFE, R. A, STUART, J. M

    Published in Immunogenetics (New York) (01-07-1991)
    “…Collagen-induced arthritis (CIA) is a rodent arthritis model in which immunization with heterologous type II collagen induces an inflammatory polyarthritis…”
    Get full text
    Journal Article
  13. 13

    Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs by Reife, R A

    Published in Advances in neurology (1998)
    “…An understanding of the pharmacokinetic and pharmacodynamic properties of a drug is a basic requirement for its clinical use. The investigations of these…”
    Get more information
    Journal Article
  14. 14

    Autoreactivity against matrilin‐1 in a patient with relapsing polychondritis by Buckner, Jane Hoyt, Wu, Jiann‐Jiu, Reife, Robert A., Terato, Kuniaki, Eyre, David R.

    Published in Arthritis and rheumatism (01-04-2000)
    “…Relapsing polychondritis (RP) is a rare inflammatory disease of cartilage. Chondritis of the auricular, nasal, and tracheal cartilages predominates in this…”
    Get full text
    Journal Article
  15. 15

    Oncostatin M stimulates excessive extracellular matrix accumulation in a transgenic mouse model of connective tissue disease by BAMBER, B, REIFE, R. A, HAUGEN, H. S, CLEGG, C. H

    “…Oncostatin M (OM), a member of the IL-6 gene family, stimulates a variety of functions implicated in wound repair. Transgenic mice that express this cytokine…”
    Get full text
    Journal Article
  16. 16

    The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis by Hasty, K A, Reife, R A, Kang, A H, Stuart, J M

    Published in Arthritis and rheumatism (01-03-1990)
    “…Articular cartilage from arthritic joints of rats immunized with type II collagen is severely depleted of proteoglycans. Depletion begins within 48 hours after…”
    Get more information
    Journal Article
  17. 17

    SWR mice are resistant to collagen-induced arthritis but produce potentially arthritogenic antibodies by Reife, R A, Loutis, N, Watson, W C, Hasty, K A, Stuart, J M

    Published in Arthritis and rheumatism (01-06-1991)
    “…SWR mice are resistant to collagen-induced arthritis but produce antibodies to type II collagen. To determine if these antibodies have arthritogenic potential,…”
    Get more information
    Journal Article
  18. 18

    Porphyromonas gingivalis Lipopolysaccharide Contains Multiple Lipid A Species That Functionally Interact with Both Toll-Like Receptors 2 and 4 by DARVEAU, Richard P, PHAM, Thu-Thao T, LEMLEY, Kayde, REIFE, Robert A, BAINBRIDGE, Brian W, COATS, Stephen R, HOWALD, William N, SING SING WAY, HAJJAR, Adeline M

    Published in Infection and Immunity (01-09-2004)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19

    MD-2 Mediates the Ability of Tetra-Acylated and Penta-Acylated Lipopolysaccharides to Antagonize Escherichia coli Lipopolysaccharide at the TLR4 Signaling Complex by Coats, Stephen R, Pham, Thu-Thao T, Bainbridge, Brian W, Reife, Robert A, Darveau, Richard P

    Published in Journal of Immunology (01-10-2005)
    “…We have demonstrated previously that tetra-acylated LPS derived from the oral bacterium, Porphyromonas gingivalis, and penta-acylated msbB LPS derived from a…”
    Get full text
    Journal Article
  20. 20